aTyr Pharma Inc LIFE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
4.25quote price arrow down-0.16 (-3.63%)
Volume
4,626
Close
4.41quote price arrow down-0.05 (-1.12%)
Volume
95,790
52 week range
2.93 - 8.33

...

Loading . . .
  • Open4.44
  • Day High4.58
  • Day Low4.41
  • Prev Close4.46
  • 52 Week High8.33
  • 52 Week High Date02/08/21
  • 52 Week Low2.93
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap70.82M
  • Shares Out16.06M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change13.66

KEY STATS

  • Open4.44
  • Day High4.58
  • Day Low4.41
  • Prev Close4.46
  • 52 Week High8.33
  • 52 Week High Date02/08/21
  • 52 Week Low2.93
  • 52 Week Low Date10/28/20
  • Market Cap70.82M
  • Shares Out16.06M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change13.66

RATIOS/PROFITABILITY

  • EPS (TTM)-2.34
  • P/E (TTM)-1.89
  • Fwd P/E (NTM)-3.10
  • EBITDA (MRQ)-24.439M
  • ROE (MRQ)-54.73%
  • Revenue (MRQ)2.39M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-1,051.76%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On aTyr Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.
John Clarke
Non-Executive Chairman
Sanjay Shukla M.D.
President
Jill Broadfoot CPA
Chief Financial Officer
Nancy Denyes J.D.
General Counsel
Address
3545 John Hopkins Ct Ste 250
San Diego, CA
92121-1115
United States

Top Peers

SYMBOLLASTCHG%CHG
VCNX
Vaccinex Inc
2.34+0.01+0.43%
ADXS
Advaxis Inc
0.4083-0.0117-2.7857%
COCP
Cocrystal Pharma Inc
1.10-0.04-3.51%
LPTX
Leap Therapeutics Inc
1.38UNCHUNCH
OTLC
Oncotelic Therapeutics Inc
0.175+0.01+6.06%